Reactant involved in synthesis of biologically active molecules including: · CGS 25966 derivatives for use as MMP inhibitors· Imidazolidinedione derivatives for use as antimalarial treatments · Pyrimidine ribonucleotide analogs as P2Y6 receptor agonists · Rab proteins for isoprenylation and geranylgeranylation inhibition Reactant involved in: · Synthesis of N-(arylethyl)-O-tert-butylhydroxamates for use as Weinreb amide equivalents· Double allylic alkylation of indole-2-hydroxamates· SN2 substitution reactions at amide nitrogens· Photocycloaddition to C=N bonds for synthesis of 1,3-diazepines
Reactant involved in synthesis of biologically active molecules including: · CGS 25966 derivatives for use as MMP inhibitors· Imidazolidinedione derivatives for use as antimalarial treatments · Pyrimidine ribonucleotide analogs as P2Y6 receptor agonists · Rab proteins for isoprenylation and geranylgeranylation inhibition Reactant involved in: · Synthesis of N-(arylethyl)-O-tert-butylhydroxamates for use as Weinreb amide equivalents· Double allylic alkylation of indole-2-hydroxamates· SN2 substitution reactions at amide nitrogens· Photocycloaddition to C=N bonds for synthesis of 1,3-diazepines
Reactant involved in synthesis of biologically active molecules including:<BR/>· CGS 25966 derivatives for use as MMP inhibitors· Imidazolidinedione derivatives for use as antimalarial treatments<BR>· Pyrimidine ribonucleotide analogs as P2Y6 receptor agonists<BR>· Rab proteins for isoprenylation and geranylgeranylation inhibition<BR/>Reactant involved in:<BR/>· Synthesis of <I>N</I>-(arylethyl)-<I>O</I>-<I>tert</I>-butylhydroxamates for use as Weinreb amide equivalents· Double allylic alkylation of indole-2-hydroxamates· SN2 substitution reactions at amide nitrogens· Photocycloaddition to C=N bonds for synthesis of 1,3-diazepines<BR>
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges